Recap: Mirum Pharmaceuticals Q2 Earnings

Mirum Pharmaceuticals MIRM reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Mirum Pharmaceuticals beat estimated earnings by 26.96%, reporting an EPS of $-0.84 versus an estimate of $-1.15.

Revenue was up $6.48 million from the same period last year.

Last quarter the company beat on EPS by $0.17 which was followed by a 0.92% increase in the share price the next day.

Here's a look at Mirum Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-1.34	0.34	-1.73
EPS Actual	-1.17	-1.65	-1.55	-1.45
Revenue Estimate	8.46M	62.65M	830K	14.50M
Revenue Actual	12.89M	3.14M	5.00M	11.00M

To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar